Acute Myeloid Leukemia Clinical Trials Database - Free Access to 644 Studies
Access comprehensive clinical trial information for Acute Myeloid Leukemia through Pure Global AI's free database. This collection includes 644 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 171 trials are actively recruiting participants.
Research for Acute Myeloid Leukemia is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include The First Affiliated Hospital of Soochow University and Gruppo Italiano Malattie EMatologiche dell'Adulto. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma.
A Pivotal Phase 3 Study of APG-2575 (Lisaftoclax) Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
DEC-C and Thioguanine for R/R AML
Oral Azacitidine Maintenance Post-CPX 351
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
MRD Response-adapted Allo-HSCT for Adverse-risk AML
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
Phase I Study of HC-7366 With Azacitidine and Venetoclax for Acute Myeloid Leukemia
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
Cladribine Venetoclax in Monocytic AML
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
Pure Global AI provides free access to 644 clinical trials studying Acute Myeloid Leukemia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include The First Affiliated Hospital of Soochow University, Gruppo Italiano Malattie EMatologiche dell'Adulto, University of Ulm, among others.